Seralutinib
N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamide
Molecular Identity
Seralutinib
N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamide
PubChem CID: 91663352
2D Structure
Properties
C27H27N5O3
Molecular Formula
469.50
Molecular Weight
g/mol
469.2114
Exact Mass
Da
3.7
XLogP
Drug-like (Lipinski: < 5)
98.3
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
667
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)C(C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OCIsomeric SMILES
SMILES: CC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)[C@H](C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OCSynonyms(20)
Seralutinib1619931-27-9Gb002PK-105713P63ZTE3OYSeralutinib [USAN]GB-002UNII-3P63ZTE3OYSERALUTINIB [WHO-DD]N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino]ethyl]phenyl]-5-methylpyridine-3-carboxamideSERALUTINIB [INN]PK10571structure 2a [WO2014110200A1]structure 2a (WO2014110200A1)N-(3-((1S)-1-((6-(3,4-DIMETHOXYPHENYL)-2-PYRAZINYL)AMINO)ETHYL)PHENYL)-5-METHYL-3-PYRIDINECARBOXAMIDE
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Seralutinib
Loading drug network...